An evidence-based analysis of Australian optometrists' dry eye practices

Optometry and Vision Science

Volumn 90, Issue 12, 2013, Pages 1385-1395

  Downie, Laura E ^a   Keller, Peter R ^a,b   Vingrys, Algis J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

cornea; dry eye; evidence based practice; lubricant; meibomian gland dysfunction; omega 3; survey; tear breakup time; tear film

Indexed keywords

BREAK-UP TIME; CORNEA; DRY EYE; EVIDENCE-BASED PRACTICES; MEIBOMIAN GLANDS; OMEGA-3; TEAR FILMS;

DISEASE CONTROL; EYE MOVEMENTS; FATTY ACIDS; GRADING; LUBRICANTS; ONLINE SYSTEMS; POLYUNSATURATED FATTY ACIDS; SUBJECTIVE TESTING; SURVEYING;

DIAGNOSIS;

FLUORESCEIN; DIAGNOSTIC AGENT;

ADULT; AUSTRALIA; CHEMISTRY; CLINICAL PRACTICE; DIAGNOSTIC USE; DRY EYE SYNDROMES; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; LACRIMAL FLUID; MEIBOMIAN GLAND; OPTOMETRY; OSMOLARITY; PHYSIOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; VISUAL SYSTEM EXAMINATION; ARTICLE; DRY EYE; STATISTICS;

ADULT; AUSTRALIA; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; EVIDENCE-BASED MEDICINE; FLUORESCEIN; HEALTH SURVEYS; HUMANS; MEIBOMIAN GLANDS; OPTOMETRY; OSMOLAR CONCENTRATION; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TEARS;

EID: 84888999762     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000087     Document Type: Article

References (53)

1. Definition and Classification Subcommittee of the International Dry Eye WorkShop. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5:75-92.
2. Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 2004;23:449-74.
3. McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Surv Ophthalmol 2012;57:293-316.
4. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007;143:409-15.
5. Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology 2003;110:1412-9.
6. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004;23:762-70.
7. Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000;19:483-6.
8. Turner AW, Layton CJ, Bron AJ. Survey of eye practitioners' attitudes towards diagnostic tests and therapies for dry eye disease. Clin Exp Ophthalmol 2005;33:351-5.
9. Cardona G, Serés C, Quevedo L, Augé M. Knowledge and use of tear film evaluation tests by spanish practitioners. Optom Vis Sci 2011; 88:1106-11.
10. Smith J, Nichols KK, Baldwin EK. Current patterns in the use of diagnostic tests in dry eye evaluation. Cornea 2008;27:656-62.
11. Graham JE, McGilligan VE, Berrar D, Leccisotti A, Moore JE, Bron AJ, Moore TC. Attitudes towards diagnostic tests and therapies for dry eye disease. Ophthalmic Res 2010;43:11-7.
12. Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5: 108-52.
13. Management and Therapy Subcommittee of the International Dry Eye WorkShop. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:163-78.
14. Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, Yee R, Yokoi N, Arita R, Dogru M. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci 2011;52:2006-49.
15. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, Rolando M, Tsubota K, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52:2050-64.
16. AustralianBureau of Statistics. 1216.0-Australian StandardGeographical Classification (ASGC), July 2010. Available at: http://www.abs.gov.au/AUSSTATS/ abs.nsf/Lookup/1216.0Main+Features1July%202010? OpenDocument. Accessed August 26, 2013.
17. Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol 1988;106:570-4.
18. Schein OD, Tielsch JM, Munoz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology 1997;104:1395-401.
19. Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, and tear osmolarity. CLAO J 1990;16:109-12.
20. Moore JE, Graham JE, Goodall EA, Dartt DA, Leccisotti A, McGilligan VE, Moore TC. Concordance between common dry eye diagnostic tests. Br J Ophthalmol 2009;93:66-72.
21. Chalmers RL, Begley CG, Edrington T, Caffery B, Nelson D, Snyder C, Simpson T. The agreement between self-assessment and clinician assessment of dry eye severity. Cornea 2005;24:804-10.
22. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118:615-21.
23. Nichols KK, Begley CG, Caffery B, Jones LA. Symptoms of ocular irritation in patients diagnosed with dry eye. Optom Vis Sci 1999;76: 838-44.
24. McMonnies CW. Key questions in a dry eye history. J Am Optom Assoc 1986;57:512-7.
25. Lee JH, Hyun PM. The reproducibility of the Schirmer test. Korean J Ophthalmol 1988;2:5-8.
26. Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, Pflugfelder SC. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010; 128:94-101.
27. Mengher LS, Bron AJ, Tonge SR, Gilbert DJ. Effect of fluorescein instillation on the pre-corneal tear film stability. Curr Eye Res 1985; 4:9-12.
28. Patel S, Murray D, McKenzie A, Shearer DS, McGrath BD. Effects of fluorescein on tear breakup time and on tear thinning time. Am J Optom Physiol Opt 1985;62:188-90.
29. Yokoi N, Komuro A. Noninvasive methods of assessing the tear film. Exp Eye Res 2004;78:399-407.
30. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272-85.
31. Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010;51:6125-30.
32. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 2003;22:640-50.
33. Farris RL. Tear osmolarityVa new gold standard? Adv Exp Med Biol 1994;350:495-503.
34. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19:201-11.
35. Tsubota K, Fujihara T, Saito K, Takeuchi T. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 1999;213:16-9.
36. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004;138: 444-57.
37. Avunduk AM, Avunduk MC, Varnell ED, Kaufman HE. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol 2003;136:593-602.
38. Sainz De La Maza Serra M, Simon Castellvi C, Kabbani O. [Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca]. Arch Soc Esp Oftalmol 2000;75:751-6.
39. Albietz JM, Bruce AS. The conjunctival epithelium in dry eye subtypes: effect of preserved and nonpreserved topical treatments. Curr Eye Res 2001;22:8-18.
40. Juturu V. Omega-3 fatty acids and the cardiometabolic syndrome. J Cardiometab Syndr 2008;3:244-53.
41. Lau CS, Morley KD, Belch JJ. Effects of fish oil supplementation on nonsteroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritisVa double-blind placebo controlled study. Br J Rheumatol 1993;32:982-9.
42. Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95:156-7.
43. Aragona P, Bucolo C, Spinella R, Giuffrida S, Ferreri G. Systemic omega-6 essential fatty acidtreatment andpge1tear content in Sjogren's syndrome patients. InvestOphthalmol Vis Sci 2005;46:4474-9.
44. Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 2005;82:887-93.
45. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye 2008;31:141-6.
46. Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc 2008;106:336-56.
47. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, McCulley JP. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 2011;30:308-14.
48. Australian Health Practitioner Regulation Agency (AHPRA). Registration Data Table June 2012. Available at: http://www.optometryboard. gov.au/About/Statistics.aspx. Accessed August 26, 2013.
49. Bourkiza R, Lee V. A review of the complications of lacrimal occlusion with punctal and canalicular plugs. Orbit 2012;31:86-93.
50. Suttle CM, Jalbert I, Alnahedh T. Examining the evidence base used by optometrists in Australia and New Zealand. Clin Exp Optom 2012;95:28-36.
51. Dry Eye Syndrome Summary Benchmarks for Preferred Practice Pattern Guidelines. American Academy of Ophthalmology. October 2012. Available at: http://one.aao.org/ce/practiceguidelines/ppp-content.aspx?cid= 127dbdce-4271-471a-b6d9-464b9d15b748. Accessed August 26, 2103.
52. Keller PR. The evidence in evidence-based practice. Why the confusion? Clin Exp Optom 2012;95:618-20.
53. ForsetlundL, Bjorndal A,RashidianA, JamtvedtG,O'BrienMA,Wolf F, Davis D, Odgaard-Jensen J, Oxman AD. Continuing education meetings and workshops: effects on professional practice and health care outcomes. CochraneDatabase Syst Rev 2009:CD003030.